Interventions to improve return to work in depressed people (Q24187462)

7

0 references

Ute Bültmann

8

object named as

Ute Bültmann

0 references

Angela Neumeyer-Gromen

4

object named as

Angela Neumeyer-Gromen

0 references

author name string

Karen Nieuwenhuijsen

1

0 references

Babs Faber

2

0 references

Jos H Verbeek

3

0 references

Hiske L Hees

5

0 references

Arco C Verhoeven

Cochrane Database of Systematic Reviews

6

0 references

publication date

3 December 2014

0 references

published in

0 references

cites work

Improving health and productivity of depressed workers: a pilot randomized controlled trial of telephone cognitive behavioral therapy delivery in workplace settings

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Psychodynamic psychotherapy and clomipramine in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Adjuvant occupational therapy improves long-term depression recovery and return-to-work in good health in sick-listed employees with major depression: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

A trial of problem-solving by community mental health nurses for anxiety, depression and life difficulties among general practice patients. The CPN-GP study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Randomized trial on the effectiveness of long- and short-term psychotherapy on psychiatric symptoms and working ability during a 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Impact of a work-focused intervention on the productivity and symptoms of employees with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Effectiveness of an exposure-based return-to-work program for workers on sick leave due to common mental disorders: a cluster-randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The effect of improving primary care depression management on employee absenteeism and productivity. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Collaborative care for sick-listed workers with major depressive disorder: a randomised controlled trial from the Netherlands Depression Initiative aimed at return to work and depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Effectiveness of a minimal psychological intervention to reduce mild to moderate depression and chronic fatigue in a working population: the design of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Resource-enhancing group intervention against depression at workplace: who benefits? A randomised controlled study with a 7-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Job terminations among persons with severe mental illness participating in supported employment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Cost-effectiveness of an activating intervention by social workers for patients with minor mental disorders on sick leave: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Work outcomes and their predictors in the Redesigning Daily Occupations (ReDO) rehabilitation programme for women with stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Individual music therapy for depression: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Long-term follow-up of a randomized controlled trial comparing acceptance and commitment therapy and standard cognitive behavior therapy for anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Telephone cognitive-behavioral therapy for subthreshold depression and presenteeism in workplace: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The community psychiatric nurse in primary care: an economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

AMITRIPTYLINE IN DEPRESSIVE STATES: SIX-MONTH TREATMENT RESULTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Quasi-experimental study on the effectiveness of psychoanalysis, long-term and short-term psychotherapy on psychiatric symptoms, work ability and functional capacity during a 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Efficacy of Cognitive Behavioral Therapy Training Using Brief E-mail Sessions in the Workplace: A Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Work-focused treatment of common mental disorders and return to work: a comparative outcome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Prevention of long-term sickness absence and major depression in high-risk employees: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Can stress management at the workplace prevent depression? A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Protocol for a randomised controlled trial investigating self-help email messages for sub-threshold depression: the Mood Memos study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The effects of primary care depression treatment on patients' clinical status and employment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Recovery from depression, work productivity, and health care costs among primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Web-based guided self-help for employees with depressive symptoms (Happy@Work): design of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The effect of IPS-modified, an early intervention for people with mood and anxiety disorders: study protocol for a randomised clinical superiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Job performance deficits due to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Update on value-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The association of medical conditions and presenteeism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Chronic physical illness, psychiatric disorder and disability in the workplace.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

A comparison of self-reported sickness absence with absences recorded in employers' registers: evidence from the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Systematic review of intervention practices for depression in the workplace

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Searching bibliographic databases for literature on chronic disease and work participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Perceptions of the impact of depression and anxiety and the medication for these conditions on safety in the workplace

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Longitudinal relationship between depressive symptoms and work outcomes in clinically treated patients with long-term sickness absence related to major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Factors associated with work participation and work functioning in depressed workers: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

What does research tell us about depression, job performance, and work productivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Work functioning measurement: tools for occupational mental health research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Duration of work disability: a comparison of self-report and administrative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Mental health status, shift work, and occupational accidents among hospital nurses in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

A meta-analysis of labor supply effects of interventions for major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Measuring sick leave: a comparison of self-reported data on sick leave and data from company records.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

A search strategy for occupational health intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Interventions to improve occupational health in depressed people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

SSRI plus supportive care more effective than supportive care alone for mild to moderate depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

Research Diagnostic Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

The functioning and well-being of depressed patients. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Amitriptyline in combination with repeated late sleep deprivation versus amitriptyline alone in major depression. A randomised study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Impact of improved depression treatment in primary care on daily functioning and disability

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

The measurement of disability.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Chronic muscle contraction headache: the importance of depression and anxiety.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Internet-based treatment for adults with depressive symptoms: the protocol of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Day and full time psychiatric treatment: a controlled comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Two forms of group therapy and individual treatment of work-related depression: a one-year follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006237.PUB3

7 January 2021

10.1002/14651858.CD006237.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25470301

1 reference

Consolidated OpenCitations Corpus – April 2017